Eriksen KW - Search Results

1

Human retinal pigment epithelial cells inhibit proliferation and IL2R expression of activated T cells.

Kaestel CG, Jørgensen A, Nielsen M, Eriksen KW, Ødum N, Holst Nissen M, Röpke C. Kaestel CG, et al. Among authors: eriksen kw. Exp Eye Res. 2002 May;74(5):627-37. doi: 10.1006/exer.2002.1183. Exp Eye Res. 2002. PMID: 12076084

2

Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells.

Nielsen M, Kaestel CG, Eriksen KW, Woetmann A, Stokkedal T, Kaltoft K, Geisler C, Röpke C, Odum N. Nielsen M, et al. Among authors: eriksen kw. Leukemia. 1999 May;13(5):735-8. doi: 10.1038/sj.leu.2401415. Leukemia. 1999. PMID: 10374878

3

Oligonucleotide fishing for STAT6: cross-talk between IL-4 and chemokines.

Eriksen KW, Nielsen M, Kaltoft K, Svejgaard A, Nissen MH, Röpke C, Ødum N. Eriksen KW, et al. Exp Clin Immunogenet. 2001;18(4):233-41. doi: 10.1159/000049202. Exp Clin Immunogenet. 2001. PMID: 11872954

4

Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins.

Woetmann A, Lovato P, Eriksen KW, Krejsgaard T, Labuda T, Zhang Q, Mathiesen AM, Geisler C, Svejgaard A, Wasik MA, Ødum N. Woetmann A, et al. Among authors: eriksen kw. Blood. 2007 Apr 15;109(8):3325-32. doi: 10.1182/blood-2006-04-017863. Epub 2006 Dec 19. Blood. 2007. PMID: 17179233 Free PMC article.

5

Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells.

Eriksen KW, Kaltoft K, Mikkelsen G, Nielsen M, Zhang Q, Geisler C, Nissen MH, Röpke C, Wasik MA, Odum N. Eriksen KW, et al. Leukemia. 2001 May;15(5):787-93. doi: 10.1038/sj.leu.2402093. Leukemia. 2001. PMID: 11368440

6

In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3.

Sommer VH, Clemmensen OJ, Nielsen O, Wasik M, Lovato P, Brender C, Eriksen KW, Woetmann A, Kaestel CG, Nissen MH, Ropke C, Skov S, Ødum N. Sommer VH, et al. Among authors: eriksen kw. Leukemia. 2004 Jul;18(7):1288-95. doi: 10.1038/sj.leu.2403385. Leukemia. 2004. PMID: 15141228

7

IFN-α primes T- and NK-cells for IL-15-mediated signaling and cytotoxicity.

Hansen ML, Woetmann A, Krejsgaard T, Kopp KL, Søkilde R, Litman T, Straten PT, Geisler C, Wasik MA, Odum N, Eriksen KW. Hansen ML, et al. Among authors: eriksen kw. Mol Immunol. 2011 Sep;48(15-16):2087-93. doi: 10.1016/j.molimm.2011.07.008. Epub 2011 Aug 2. Mol Immunol. 2011. PMID: 21813181

8

Bi-phasic effect of interferon (IFN)-alpha: IFN-alpha up- and down-regulates interleukin-4 signaling in human T cells.

Eriksen KW, Sommer VH, Woetmann A, Rasmussen AB, Brender C, Svejgaard A, Skov S, Geisler C, Ødum N. Eriksen KW, et al. J Biol Chem. 2004 Jan 2;279(1):169-76. doi: 10.1074/jbc.M310472200. Epub 2003 Oct 14. J Biol Chem. 2004. PMID: 14559900 Free article.

9

Increased sensitivity to interferon-alpha in psoriatic T cells.

Eriksen KW, Lovato P, Skov L, Krejsgaard T, Kaltoft K, Geisler C, Ødum N. Eriksen KW, et al. J Invest Dermatol. 2005 Nov;125(5):936-44. doi: 10.1111/j.0022-202X.2005.23864.x. J Invest Dermatol. 2005. PMID: 16297193 Free article.

10

The CC-chemokine receptor 5 (CCR5) is a marker of, but not essential for the development of human Th1 cells.

Odum N, Bregenholt S, Eriksen KW, Skov S, Ryder LP, Bendtzen K, Van Neerven RJ, Svejgaard A, Garred P. Odum N, et al. Among authors: eriksen kw. Tissue Antigens. 1999 Dec;54(6):572-7. doi: 10.1034/j.1399-0039.1999.540606.x. Tissue Antigens. 1999. PMID: 10674971

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page